BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 19054060)

  • 1. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
    Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
    Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
    Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
    Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an effective method for dendritic cell immunotherapy of mouse melanoma.
    Lee TH; Cho HK; Cho YH; Lee MG
    Scand J Immunol; 2009 Aug; 70(2):85-92. PubMed ID: 19630913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.
    Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU
    J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection.
    Demangel C; Palendira U; Feng CG; Heath AW; Bean AG; Britton WJ
    Infect Immun; 2001 Apr; 69(4):2456-61. PubMed ID: 11254607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.
    Wei H; Wang H; Lu B; Li B; Hou S; Qian W; Fan K; Dai J; Zhao J; Guo Y
    Cancer Res; 2008 May; 68(10):3854-62. PubMed ID: 18483270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
    Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
    Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells.
    Kuniyoshi JS; Kuniyoshi CJ; Lim AM; Wang FY; Bade ER; Lau R; Thomas EK; Weber JS
    Cell Immunol; 1999 Apr; 193(1):48-58. PubMed ID: 10202112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma-induced inhibition of dendritic cell IL-12 production via abrogation of CD40 expression.
    Walker SR; Redlinger RE; Barksdale EM
    J Pediatr Surg; 2005 Jan; 40(1):244-9; discussion 249-50. PubMed ID: 15868592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 18 transfection enhances antitumor immunity induced by dendritic cell-tumor cell conjugates.
    Ju DW; Tao Q; Lou G; Bai M; He L; Yang Y; Cao X
    Cancer Res; 2001 May; 61(9):3735-40. PubMed ID: 11325846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.
    Zhang X; Kedl RM; Xiang J
    Biochem Biophys Res Commun; 2009 Feb; 379(4):954-8. PubMed ID: 19135981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo.
    Pulendran B; Dillon S; Joseph C; Curiel T; Banchereau J; Mohamadzadeh M
    Eur J Immunol; 2004 Jan; 34(1):66-73. PubMed ID: 14971031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40L-expressing CD8 T cells prime CD8alpha(+) DC for IL-12p70 production.
    Wong KL; Lew FC; MacAry PA; Kemeny DM
    Eur J Immunol; 2008 Aug; 38(8):2251-62. PubMed ID: 18600823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
    J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.